Fax: (713) 745-6839
Original Article
You have free access to this content
Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients
A retrospective, single-institution study
Article first published online: 23 JUN 2009
DOI: 10.1002/cncr.24480
Copyright © 2009 American Cancer Society
Additional Information
How to Cite
Granger, J. M. and Kontoyiannis, D. P. (2009), Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients. Cancer, 115: 3919–3923. doi: 10.1002/cncr.24480
Publication History
- Issue published online: 20 AUG 2009
- Article first published online: 23 JUN 2009
- Manuscript Accepted: 5 FEB 2009
- Manuscript Revised: 23 JAN 2009
- Manuscript Received: 2 DEC 2008
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , Why Does My Patient Have Leukocytosis?, Hematology/Oncology Clinics of North America, 2012, 26, 2, 303
- 2, , , , , , , , , , Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer, Gynecologic Oncology, 2011, 122, 1, 25
- 3
- 4, , , , , , , , , , , , , , , , , , , , , Inaugural Article: Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes, Proceedings of the National Academy of Sciences, 2010, 107, 50, 21248
- 5, , Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment, Mayo Clinic Proceedings, 2010, 85, 9, 838

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)